Share-based Payment Arrangement, Expense of MEDICINOVA INC from 30 Jun 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
MEDICINOVA INC quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2018 to 30 Sep 2025.
  • MEDICINOVA INC Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $157,692, a 69% decline year-over-year.
  • MEDICINOVA INC Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $912,525, a 32% increase year-over-year.
  • MEDICINOVA INC annual Share-based Payment Arrangement, Expense for 2024 was $1,191,740, a 68% increase from 2023.
  • MEDICINOVA INC annual Share-based Payment Arrangement, Expense for 2023 was $710,710, a 11% increase from 2022.
  • MEDICINOVA INC annual Share-based Payment Arrangement, Expense for 2022 was $642,522, a 63% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

MEDICINOVA INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $912,525 $157,692 -$347,170 -69% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $1,259,695 $204,897 -$2,558 -1.2% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $1,262,253 $285,943 +$70,513 +33% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $1,191,740 $263,993 +$501,398 01 Oct 2024 31 Dec 2024 10-K 19 Feb 2025 2024 FY
Q3 2024 $690,342 $504,862 +$285,720 +130% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $404,622 $207,455 -$118,255 -36% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 $522,877 $215,430 -$187,833 -47% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q4 2023 $710,710 $237,405 -$366,074 -285% 01 Oct 2023 31 Dec 2023 10-K 19 Feb 2025 2024 FY
Q3 2023 $1,076,784 $219,142 +$60,844 +38% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 $1,015,940 $325,710 +$51,208 +19% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $964,732 $403,263 +$322,210 +398% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $642,522 $128,669 +$885,641 01 Oct 2022 31 Dec 2022 10-K 15 Feb 2024 2023 FY
Q3 2022 $243,119 $158,298 -$420,646 -73% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $177,527 $274,502 -$481,403 -64% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q1
Q1 2022 $658,930 $81,053 -$1,058,583 -93% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $1,717,513 $756,972 -$1,155,022 -290% 01 Oct 2021 31 Dec 2021 10-K/A 28 Mar 2023 2022 FY
Q3 2021 $2,872,535 $578,944 -$455,027 -44% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 $3,327,562 $755,905 -$391,249 -34% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 $3,718,811 $1,139,636 +$543,258 +91% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $3,175,553 $398,050 +$1,201,259 01 Oct 2020 31 Dec 2020 10-K 16 Feb 2022 2021 FY
Q3 2020 $1,974,294 $1,033,971 +$660,127 +177% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3
Q2 2020 $1,314,167 $1,147,154 -$695,360 -38% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $2,009,527 $596,378 -$2,103,122 -78% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q4 2019 $4,112,649 $803,209 01 Oct 2019 31 Dec 2019 10-K 19 Feb 2021 2020 FY
Q3 2019 $373,844 -$4,354,416 -92% 01 Jul 2019 30 Sep 2019 10-Q 26 Oct 2020 2020 Q3
Q2 2019 $1,842,514 +$1,019,302 +124% 01 Apr 2019 30 Jun 2019 10-Q 28 Jul 2020 2020 Q2
Q1 2019 $2,699,500 01 Jan 2019 31 Mar 2019 10-Q 23 Apr 2020 2020 Q1
Q3 2018 $4,728,260 01 Jul 2018 30 Sep 2018 10-Q 24 Oct 2019 2019 Q3
Q2 2018 $823,212 01 Apr 2018 30 Jun 2018 10-Q 25 Jul 2019 2019 Q2

MEDICINOVA INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,191,740 +$481,030 +68% 01 Jan 2024 31 Dec 2024 10-K 19 Feb 2025 2024 FY
2023 $710,710 +$68,188 +11% 01 Jan 2023 31 Dec 2023 10-K 19 Feb 2025 2024 FY
2022 $642,522 -$1,074,991 -63% 01 Jan 2022 31 Dec 2022 10-K 15 Feb 2024 2023 FY
2021 $1,717,513 -$1,458,040 -46% 01 Jan 2021 31 Dec 2021 10-K/A 28 Mar 2023 2022 FY
2020 $3,175,553 -$937,096 -23% 01 Jan 2020 31 Dec 2020 10-K 16 Feb 2022 2021 FY
2019 $4,112,649 -$2,217,656 -35% 01 Jan 2019 31 Dec 2019 10-K 19 Feb 2021 2020 FY
2018 $6,330,305 01 Jan 2018 31 Dec 2018 10-K 13 Feb 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.